Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up
Almost two months into 2021, the market appears undecided about where it is heading next. In fact, many investors fear the market is due for a serious correction, especially for the wide selection of richly valued stocks. It is an environment that requires fussier stock picking. Or maybe its prudent to turn in such times to the best at spotting where the next opportunity lies. And for best, we mean the cream of the crop the finest analysts on Wall Street. Weve pulled up the details on 3 stocks that…
